Treatment Considerations in WM
The following abstracts represent the presentations given at IWWM-8 (London-2014), Session-11:
Session Chair: E. Morra
Integrating signal inhibitors into WM therapy I. Ghobrial (USA)
Rituximab intolerance and alternatives in WM S. Kanan (USA)
Diagnosis and workup of the patient with amyloidosis G. Merlini (Italy)
Optimal timing for stem cell transplant in WM C. Kyriakou (UK)
Long term toxicity of therapy in WM E. Morra (Italy)
Special Luncheon Lecture:
Current Treatment Approaches to Waldenström’s macroglobulinemia in the United Kingdom S. D'Sa (UK)